Achieve Life Sciences, Inc. · NASDAQ:ACHV
Parker Quillen's stake in Achieve Life Sciences, Inc. fell to 4.90% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Parker Quillen's stake in Achieve Life Sciences, Inc. fell to 4.90%, 2,528,377 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 2,528,377
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Contrarian Alpha, LP | 1.10% | 550,000 |
| Contrarian Achieve SPV, LP | 3.80% | 1,978,377 |
| Contrarian Achieve GP LLC | 3.80% | 1,978,377 |
| Contrarian Alpha GP, LLC | 1.10% | 550,000 |
| Contrarian Alpha Management, LLC | 1.10% | 550,000 |
| Parker Quillen | 4.90% | 2,528,377 |
Source
Related
- Achieve Life Sciences, Inc.
- Parker Quillen
- Achieve Life Sciences, Inc. shareholders
- Form 4 · Stewart Richard Alistair · Aug 21, 2026
- Schedule 13G · Logos Global Management LP · Aug 17, 2026
- Schedule 13G · Janus Henderson Group PLC · Aug 13, 2026
- Schedule 13G/A · Franklin Resources Inc · Jul 28, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026